Trevi Therapeutics (TRVI) Other Non Operating Income (2021 - 2022)

Trevi Therapeutics' Other Non Operating Income history runs 5 years deep, the most recent figure standing at $30000.0 for Q4 2025.

• In Q4 2025, Other Non Operating Income fell 96.71% year-over-year to $30000.0; the TTM figure through Dec 2025 stood at $933000.0 (up 4.25% YoY), while the FY2025 annual figure was $14000.0, down 98.44% from the prior year.
• Other Non Operating Income for Q4 2025 stood at $30000.0, up from -$2000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $5.5 million in Q4 2022, with the low at -$404000.0 in Q4 2021.
• The 5-year median for Other Non Operating Income is -$2500.0 (2023), against an average of $356111.1.
• The sharpest annual moves came in 2022 and 2024: Other Non Operating Income plunged 440.0% in 2022, then jumped 30500.0% in 2024.
• Trevi Therapeutics' Other Non Operating Income stood at -$404000.0 in 2021, then soared by 1473.02% to $5.5 million in 2022, then slumped by 100.05% to -$3000.0 in 2023, then surged by 30500.0% to $912000.0 in 2024, then slumped by 96.71% to $30000.0 in 2025.
• Business Quant data shows TRVI's Other Non Operating Income at $30000.0 in Q4 2025, -$2000.0 in Q3 2025, and -$7000.0 in Q2 2025.